
Neil L. Berinstein, Michael McNamara, Ariane Nguyen, James Egan & Gregory T. Wolf, et al. , OncoImmunology, DOI: 10.1080/2162402X.2017.1423173›
Freeman SM, Barrera Franco JL, Kenady DE, et al. Am J Clin Oncol. 2011;34(2):173-178.›
Wolf GT, Fee WE Jr, Dolan RW, et al. Head Neck. 2011;33(12):1666-1674.›
Whiteside TL, Butterfield LH, Naylor PH, et al. Cancer Immunol Immunother. 2012;61(6):783-738.›
Berinstein NL, Wolf GT, Naylor PH, et al. Cancer Immunol Immunother. 2012;61(6):771-782.›
Czystowska M, Han J, Szczepanski MJ, et al. Cell Death Differ. 2009;16(5):708-718.›
Czystowska M, Szczepanski MJ, Szajnik M, et al. Cancer Immunol Immunother. 2011;60(4):495-506.›
Egan JE, Quadrini KJ, Santiago-Schwarz F, Hadden JW, Brandwein HJ, Signorelli KL. J Immunother. 2007;30(6):624-633.›
Schilling B, Harasymczuk M, Schuler P, Egan J, Ferrone S, Whiteside TL. PLoS One. 2013;8(2):e47234.›
Schilling B, Harasymczuk M, Schuler P, Egan JE, Whiteside TL. J Mol Med (Berl). 2012;90(2):139-147.›
Schilling B, Halstead ES, Schuler P, Harasymczuk M, Egan JE, Whiteside TL. Cancer Immunol Immunother. 2012;61(9):1395-1405.›
Naylor PH, Hernandez KE, Nixon AE, et al. Vaccine. 2010;28(43):7054-7062.›
Naylor PH, Egan JE, Berinstein NL. Cancers (Basel). 2011;3(4):3991-4009.›